KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Okta (OKTA) Cash & Equivalents (2016 - 2026)

Okta (OKTA) has 11 years of Cash & Equivalents data on record, last reported at $858.0 million in Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 109.78% year-over-year to $858.0 million; the TTM value through Jan 2026 reached $858.0 million, up 109.78%, while the annual FY2026 figure was $858.0 million, 109.78% up from the prior year.
  • Cash & Equivalents reached $858.0 million in Q1 2026 per OKTA's latest filing, up from $645.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $876.0 million in Q3 2025 and bottomed at $125.0 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $401.6 million, with a median of $334.0 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 70.6% in 2022, then surged 157.6% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $250.0 million in 2022, then skyrocketed by 60.0% to $400.0 million in 2023, then fell by 22.5% to $310.0 million in 2024, then skyrocketed by 108.06% to $645.0 million in 2025, then skyrocketed by 33.02% to $858.0 million in 2026.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $858.0 million in Q1 2026, $645.0 million in Q4 2025, and $876.0 million in Q3 2025.